Main Catalog

Found 95
Sort By
Nexus Conferences
Member Free
Non-Member $30.00
VIEW CART

Specialty Pharmaceuticals in Development - Nexus 2018

Contact Hours: 1.25. Over the last several years, approvals of specialty pharmaceuticals have far outpaced those of traditional drugs. It is anticipated that this trend will continue.
Specialty
AMCP Annual Meeting
Member Free
Non-Member $30.00
VIEW CART

Real-World Experience Managing Orphan Drugs Across Pharmacy and Medical Benefits

Contact Hours: 1.25. Recently approved drugs for orphan diseases have annual costs ranging from $90,000 to over $1 million, while also having variable value propositions.
Orphan Disease
AMCP Annual Meeting
Member Free
Non-Member $30.00
VIEW CART

Pulmonary Arterial Hypertension and the Managed Care Considerations for Formulary Decision-Making

Contact Hours: 1.25. Patients with pulmonary arterial hypertension (PAH) currently have a 60% five-year survival outlook, which has been increasing since the 1980s when it was a 37% five-year outlook.
Pulmonary Arterial Hypertension
Webinars
Member Free
Non-Member Free
VIEW CART

Navigating Changes in Clostridioides difficile Prevention and Treatment - Home Study

Contact Hours: 1. 5 - Clostridioides difficile (C. diff, previously known as Clostridium difficile) infections are a major health care concern.
C. Diff
AMCP Annual Meeting
Member Free
Non-Member $30.00
VIEW CART

More than Meets the Eye–Value-Based Contracts are More Prevalent than We Think

Contact Hours: 1.25. As the U.S. health care system evolves from a volume-driven system to one that rewards value, there is growing interest in value-based payment arrangements.
Value-Based Contracting
AMCP Annual Meeting
Member Free
Non-Member $30.00
VIEW CART

Medicare Formulary Updates Impact

Contact Hours: 1.25. The Centers for Medicare and Medicaid (CMS) continues to critically evaluate formulary regulations and guidance to help lower drug costs.
Medicare
AMCP eLearning Days
Member Free
Non-Member $30.00
VIEW CART

Digital Therapeutics: Understanding the Emerging Product Class Home Study

Contact Hours: 1 - Digital therapeutics (DTx) are emerging as a novel treatment modality for a wide range of health conditions, either as stand-alone products or for use in conjunction with other treatments.
Digital Health AMCP eLearning Days
AMCP Annual Meeting
Member Free
Non-Member $30.00
VIEW CART

Measuring Value of an IDN Specialty Pharmacy Therapy Management Program for Biologics

Contact Hours: 1.25: Gene therapy is a promising treatment option for a number of diseases, including inherited disorders, some types of cancer, and certain viral infections. The first gene therapy approvals in the United States occurred in 2017.
Specialty
AMCP Annual Meeting
Member Free
Non-Member $30.00
VIEW CART

Key Forces Driving Change in Oncology

Contact Hours: 1.25. Oncology practice is changing rapidly as new advances in innovation lead to new evidence and testing requirements, as well as treatment guidelines.
Oncology
AMCP Annual Meeting
Member Free
Non-Member $30.00
VIEW CART

It’s an ART: Formulary and Drug Use Management Strategies for HIV Medications - Annual 2019

Contact Hours: 1.25. As people with HIV age, the focus of disease management places more emphasis on the safety of long-term medication use and managing comorbidities. The advantages of safer, more efficacious medications also come with increased cost.
HIV